I will require 503A drug compounders to report to the FDA any out-of-state shipments of compounded drugs containing approved active ingredients above a prescription threshold.

Jim Banks · Indiana · Republican

policy impact 5.00 specificity 1.00 extraction confidence 98%

Contest this claim

Occurrences

if a pharmacy, facility, or physician compounds, more than 20 times in a single month for patients who reside outside the State in which the compounding occurs, any drug product that contains any active ingredient found in a commercially available drug product ... shall submit a report to the Secretary

The bill would require reporting to HHS when a compounder makes the covered drug more than 20 times in a month for out-of-state patients.

BILLS-119s3794is.pdf
primary · other · model gpt-5.4-mini

Evidence

The Senate office’s legislation page lists S.3794, the SAFE Drugs Act of 2026, with latest action: 'Read twice and referred to the Committee on Health, Education, Labor, and Pensions.'

Banks introduced the bill, but the latest official action shown is committee referral, not enactment or implementation of the reporting requirement.

unresolved same_term A for effort

Legislation - Senator Jim Banks
primary · model gpt-5.4-mini · confidence 92%

Contest this evidence item

Banks said he introduced the SAFE Drugs Act, and the listed key provisions include: 'Require 503A compounders to report to the FDA any out-of-state shipments of compounded drugs containing approved active ingredients above a prescription threshold.'

This is a concrete legislative attempt matching the claim, but it only shows proposal and introduction, not delivery.

partial same_term A for effort

Senator Jim Banks Introduces SAFE Drugs Act to Crack Down on Risky and Fraudulent Weight Loss Drugs
primary · model gpt-5.4-mini · confidence 95%

Contest this evidence item

Assessments

never same_term A for effort

Banks introduced S.3794, the SAFE Drugs Act of 2026, which directly included the promised requirement for 503A compounders to report qualifying out-of-state shipments to FDA. However, current official bill status shows the measure only reached introduction and referral to the Senate HELP Committee on February 5, 2026, with no enactment or implementation. This is a serious same-term legislative attempt, but the promised federal requirement has not been delivered.

provider codex_cli · model gpt-5.5 · confidence 94%